These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31832114)

  • 1. TMT-based quantitative proteomics revealed follicle-stimulating hormone (FSH)-related molecular characterizations for potentially prognostic assessment and personalized treatment of FSH-positive non-functional pituitary adenomas.
    Wang Y; Cheng T; Lu M; Mu Y; Li B; Li X; Zhan X
    EPMA J; 2019 Dec; 10(4):395-414. PubMed ID: 31832114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of quantitative phosphoproteomics and transcriptomics revealed phosphorylation-mediated molecular events as useful tools for a potential patient stratification and personalized treatment of human nonfunctional pituitary adenomas.
    Liu D; Li J; Li N; Lu M; Wen S; Zhan X
    EPMA J; 2020 Sep; 11(3):419-467. PubMed ID: 32849927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity analysis of the proteomes in clinically nonfunctional pituitary adenomas.
    Zhan X; Wang X; Long Y; Desiderio DM
    BMC Med Genomics; 2014 Dec; 7():69. PubMed ID: 25539738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Important Invasion-Related Genes in Non-functional Pituitary Adenomas.
    Joshi H; Vastrad B; Vastrad C
    J Mol Neurosci; 2019 Aug; 68(4):565-589. PubMed ID: 30982163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Analysis of Proteome in Non-functional Pituitary Adenomas: Clinical Relevance and Potential Benefits for the Patients.
    Cheng T; Wang Y; Lu M; Zhan X; Zhou T; Li B; Zhan X
    Front Endocrinol (Lausanne); 2019; 10():854. PubMed ID: 31920968
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiomics-Based Signaling Pathway Network Alterations in Human Non-functional Pituitary Adenomas.
    Long Y; Lu M; Cheng T; Zhan X; Zhan X
    Front Endocrinol (Lausanne); 2019; 10():835. PubMed ID: 31920959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the proteomic variations of invasive relative to non-invasive non-functional pituitary adenomas.
    Zhan X; Desiderio DM; Wang X; Zhan X; Guo T; Li M; Peng F; Chen X; Yang H; Zhang P; Li X; Chen Z
    Electrophoresis; 2014 Aug; 35(15):2184-94. PubMed ID: 24729304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative phosphoproteomics reveals molecular pathway network alterations in human early-stage primary hepatic carcinomas: potential for 3P medical approach.
    Zhang Y; Li N; Yang L; Jia W; Li Z; Shao Q; Zhan X
    EPMA J; 2023 Sep; 14(3):477-502. PubMed ID: 37605650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Invasive-Related Biomarker in Three Subtypes of Nonfunctioning Pituitary Adenomas.
    Chen Y; Chuan HL; Yu SY; Li CZ; Wu ZB; Li GL; Zhang YZ
    World Neurosurg; 2017 Apr; 100():514-521. PubMed ID: 28093347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor mechanism of kangliu pill on gliomas in mice through PI3K-Akt signaling pathway.
    Chen F; Cui JJ; Jiang DC; Wang HZ; Zhuang W; Feng YN; Lin XL; Xi SY
    J Ethnopharmacol; 2023 May; 307():116252. PubMed ID: 36775078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic Analysis of the Sphincter in a Neurogenic Bladder Caused by T10 Spinal Cord Injury.
    Qu QR; Tang LY; Liu Q; Long YY; Wu X; Xu M; Qi F; Zhang H; Ai K; Zhou L
    J Integr Neurosci; 2022 Aug; 21(5):147. PubMed ID: 36137973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic and functional profiles of a follicle-stimulating hormone positive human nonfunctional pituitary adenoma.
    Wang X; Guo T; Peng F; Long Y; Mu Y; Yang H; Ye N; Li X; Zhan X
    Electrophoresis; 2015 Jun; 36(11-12):1289-304. PubMed ID: 25809007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative proteomics and transcriptomics identify novel invasive-related biomarkers of non-functioning pituitary adenomas.
    Yu SY; Hong LC; Feng J; Wu YT; Zhang YZ
    Tumour Biol; 2016 Jul; 37(7):8923-30. PubMed ID: 26753958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas.
    Feng J; Hong L; Wu Y; Li C; Wan H; Li G; Sun Y; Yu S; Chittiboina P; Montgomery B; Zhuang Z; Zhang Y
    J Neurooncol; 2014 Sep; 119(2):307-15. PubMed ID: 24916845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative proteomics identified a novel invasion biomarker associated with EMT in pituitary adenomas.
    Zhang Y; Li L; Ma X; Liu C; Liu G; Bie Z; Yang Z; Liu P
    Front Endocrinol (Lausanne); 2023; 14():1137648. PubMed ID: 36936141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into pathogenesis of congenital pseudarthrosis of tibia in children using periosteum proteomics analysis.
    Liu Y; Qin ZQ; Zheng Y; Wu J; Yang G; Tan Q; Zhu G; Liu K; Mei H
    Rapid Commun Mass Spectrom; 2022 Nov; 36(21):e9374. PubMed ID: 35933588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Differential Expression Proteins of Paclitaxel-Treated Lung Adenocarcinoma Cell A549 Using Tandem Mass Tag-Based Quantitative Proteomics.
    Zheng W; Xu S
    Onco Targets Ther; 2020; 13():10297-10313. PubMed ID: 33116610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitinomics revealed disease- and stage-specific patterns relevant for the 3PM approach in human sigmoid colon cancers.
    Yang H; Li N; Chen L; Zhou L; Zhou Y; Liu J; Jia W; Chen R; Su J; Yang L; Gong X; Zhan X
    EPMA J; 2023 Sep; 14(3):503-525. PubMed ID: 37605648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of RFRP‑3 on an ovariectomized estrogen‑primed rat model and HEC‑1A human endometrial carcinoma cells.
    Zhao X; Si L; Niu L; Wei M; Wang F; Liu X; Chen Z; Qiao Y; Cheng L; Yang S
    Exp Ther Med; 2023 Feb; 25(2):76. PubMed ID: 36684658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tandem mass tag-based proteomics analysis reveals the multitarget mechanisms of
    Gong P; Yin K; Luo X; Gu J; Tan R; Wu Y; Li D
    Front Pharmacol; 2022; 13():989995. PubMed ID: 36313326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.